A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
2017-11-18
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare LY900014 with insulin lispro (Humalog) in elderly and
younger adults with type 1 diabetes mellitus.
Screening is required within 28 days prior to the start of the study. For each participant,
the total duration of the clinical trial will be between 3 to 8 weeks.